BACKGROUND: The emergence of antibiotic resistance in pathogenic bacteria has become a global threat, encouraging the adoption of efficient and effective alternatives to conventional antibiotics and promoting their use as replacements. Titanium dioxide nanoparticles (TiO2 NPs) have been reported to exhibit antibacterial properties. In this study, we synthesized and characterized TiO2 NPs in anatase and rutile forms with surface modification by geraniol (GER). RESULTS: The crystallinity and morphology of modified TiO2 NPs were analyzed by UV/Vis spectrophotometry, X-ray powder diffraction (XRD), and scanning electron microscopy (SEM) with elemental mapping (EDS). The antimicrobial activity of TiO2 NPs with geraniol was assessed against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia coli. The minimum inhibitory concentration (MIC) values of modified NPs ranged from 0.25 to 1.0 mg/ml against all bacterial strains, and the live dead assay and fractional inhibitory concentration (FIC) supported the antibacterial properties of TiO2 NPs with GER. Moreover, TiO2 NPs with GER also showed a significant decrease in the biofilm thickness of MRSA. CONCLUSIONS: Our results suggest that TiO2 NPs with GER offer a promising alternative to antibiotics, particularly for controlling antibiotic-resistant strains. The surface modification of TiO2 NPs by geraniol resulted in enhanced antibacterial properties against multiple bacterial strains, including antibiotic-resistant MRSA. The potential applications of modified TiO2 NPs in the biomedical and environmental fields warrant further investigation.

Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic

Department of Inorganic Chemistry Faculty of Science Palacky University Olomouc Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23016623

003      

CZ-PrNML

005      

20231026105654.0

007      

ta

008      

231013s2023 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1186/s12866-023-02955-1 $2 doi

035    __

$a (PubMed)37528354

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Younis, Almotasem Bellah $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

245    10

$a Synthesis and characterization of TiO2 nanoparticles combined with geraniol and their synergistic antibacterial activity / $c AB. Younis, V. Milosavljevic, T. Fialova, K. Smerkova, H. Michalkova, P. Svec, P. Antal, P. Kopel, V. Adam, L. Zurek, K. Dolezelikova

520    9_

$a BACKGROUND: The emergence of antibiotic resistance in pathogenic bacteria has become a global threat, encouraging the adoption of efficient and effective alternatives to conventional antibiotics and promoting their use as replacements. Titanium dioxide nanoparticles (TiO2 NPs) have been reported to exhibit antibacterial properties. In this study, we synthesized and characterized TiO2 NPs in anatase and rutile forms with surface modification by geraniol (GER). RESULTS: The crystallinity and morphology of modified TiO2 NPs were analyzed by UV/Vis spectrophotometry, X-ray powder diffraction (XRD), and scanning electron microscopy (SEM) with elemental mapping (EDS). The antimicrobial activity of TiO2 NPs with geraniol was assessed against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia coli. The minimum inhibitory concentration (MIC) values of modified NPs ranged from 0.25 to 1.0 mg/ml against all bacterial strains, and the live dead assay and fractional inhibitory concentration (FIC) supported the antibacterial properties of TiO2 NPs with GER. Moreover, TiO2 NPs with GER also showed a significant decrease in the biofilm thickness of MRSA. CONCLUSIONS: Our results suggest that TiO2 NPs with GER offer a promising alternative to antibiotics, particularly for controlling antibiotic-resistant strains. The surface modification of TiO2 NPs by geraniol resulted in enhanced antibacterial properties against multiple bacterial strains, including antibiotic-resistant MRSA. The potential applications of modified TiO2 NPs in the biomedical and environmental fields warrant further investigation.

650    12

$a methicilin rezistentní Staphylococcus aureus $7 D055624

650    _2

$a antibakteriální látky $x farmakologie $7 D000900

650    12

$a nanočástice $7 D053758

650    _2

$a Bacteria $7 D001419

650    _2

$a mikrobiální testy citlivosti $7 D008826

650    12

$a kovové nanočástice $7 D053768

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Milosavljevic, Vedran $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Fialova, Tatiana $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Smerkova, Kristyna $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Michalkova, Hana $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Svec, Pavel $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Antal, Peter $u Department of Inorganic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic

700    1_

$a Kopel, Pavel $u Department of Inorganic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic

700    1_

$a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Zurek, Ludek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Dolezelikova, Kristyna $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic. kriki.cihalova@seznam.cz

773    0_

$w MED00008191 $t BMC microbiology $x 1471-2180 $g Roč. 23, č. 1 (2023), s. 207

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37528354 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20231013 $b ABA008

991    __

$a 20231026105649 $b ABA008

999    __

$a ok $b bmc $g 2000253 $s 1202985

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 23 $c 1 $d 207 $e 20230802 $i 1471-2180 $m BMC microbiology $n BMC Microbiol $x MED00008191

LZP    __

$a Pubmed-20231013